Bruce Goldsmith is currently a member of the Board of Directors at Nobias Therapeutics and serves as an Operating Partner at ALSA Ventures. They have held significant roles, including Chief Executive Officer at Passage Bio and Interim CEO at Civetta Therapeutics. Goldsmith has a background in strategic marketing as a Global Marketing Leader at Johnson & Johnson and Vice President of Strategic Marketing at GPC Biotech. They earned their degree from Columbia University - Columbia Business School and have also worked as a Venture Partner at Deerfield Management and UTEC - The University of Tokyo Edge Capital Partners.
This person is not in the org chart
This person is not in any teams
This person is not in any offices